Cancer stem cells are identified and can be isolated based on the expression of specific cell-surface proteins that act as molecular biomarkers, among which the most frequent markers are CD44, CD133, CD24, the epithelial cell adhesion molecule (EpCAM), and the leucine-rich repeat-containing G-protein coupled receptor 5 (LGR5) (Table 1). This evidence concerns the gene CD44 and cancer.